Regulations.gov document
Final Decisions; Availability: Withdrawal of Breast Cancer Indication for AVASTIN…
Notice · FDA-2010-N-0621 · posted Feb 27, 2012
Key facts
| Document ID | FDA-2010-N-0621-0545 |
|---|---|
| Title | Final Decisions; Availability: Withdrawal of Breast Cancer Indication for AVASTIN (Bevacizumab) |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2010-N-0621 |
| Posted | Feb 27, 2012 |
| Federal Register citation | 77 FR 11554 |
| FR document number | 2012-04424 |
| Comment period opens | Feb 27, 2012 |
| Effective date | Feb 27, 2012 |
At a glance
- 1–9 Pages
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: